LDL受体介导的血浆低密度脂蛋白胆固醇的内吞

胆固醇是动物细胞细胞膜的重要组成成分,其做为细胞和环境之间的屏障调节细胞膜的流动性。胆固醇是体内所有的类固醇激素和胆酸合成的前体物质,参与体内代谢。同时胆固醇在神经系统的发育中也起着重要的作用。在血浆中胆固醇以低密度脂蛋白和高密度脂蛋白这两种胆固醇运载血脂蛋白的形式运输。动物细胞通过细胞表面的低密度脂蛋白受体(LDL receptor,LDLR)介导的内吞可以从血液中摄取富含胆固醇的低密度脂蛋白,当细胞表面的LDLR的功能缺陷时,可以导致高胆固醇血症,继而引起动脉粥样硬化、冠心病和中风等严重疾病。本文综述了LDL受体的概述及其通过内吞调节血液中低密度脂蛋白胆固醇水平的作用,并对LDL受体的调节进行了阐述。     

转铁蛋白受体及其在药物运输中的作用

血脑屏障的存在阻止了中枢神经系统疾病许多潜在治疗药物的通过.近年来主要利用脑毛细血管内皮细胞膜中的转运蛋白,如转铁蛋白受体、胰岛素受体等,将外源药物与这些受体的特异性抗体相连,通过受体介导的内吞作用将药物转运到脑组织中.转铁蛋白受体在抗癌药物定向运输及恶性肿瘤细胞基因治疗中的研究已经处于临床阶段.     

受体介导内吞引起的巨噬细胞胞质酸化和胞吐作用

本文利用激光扫描共聚焦显微镜A-CAS570从细胞形态学和功能两方面,研究了刀豆素A(Concanavalin A,Con A)、麦芽凝集素(Wheat Germ Agglutinin,WGA)、酵母多糖(Zymosan A,Z.A)对小鼠腹腔巨噬细胞胞质pH和溶酶体内荧光探针FITC—Dextran排出细胞的影响。结果显示三种配体加入细胞外液10min内,胞质pH很快下降,此后维持在该水平;在15min左右细胞外FITC一Dextran迅速增加,20min后变化趋于停止;在三种配体加入后15min左右,细胞内溶酶体在质膜内侧增多;25—30min溶酶体重新向细胞中央运动。根据上述实验结果,我们认为溶酶体pH升高是触发溶酶体内荧光探针通过胞吐作用排出细胞的必要条件,胞质酸化抑制溶酶体内容物通过胞吐作用排出细胞。配体刺激引起的溶酶体内容物通过胞吐作用排出细胞和胞质酸化是细胞自我调节和保护的一种反映。     

受体介导内吞对巨噬细胞膜电位、胞浆和溶酶体pH的影响

本文利用荧光标记方法测定了刀豆素Ａ、麦芽凝集素、酵母多糖刺激引起的巨噬细胞膜电位、胞浆ｐＨ溶酶体ｐＨ的变化。结果显示三种配体均导致细胞膜电位超极化,胞浆ｐＨ降低、溶酶体ｐＨ或高,三个生理参量趋于稳定时间稍有不同。胞浆ｐＨ的降低可能有抑制内吞的作用,溶酶体ｐＨ上升是触发溶酶体内容物外排的基本因素。内吞引起的这些变化是细胞代谢过程中自我调节和保护的表现。     

uPA与其抑制剂复合物的受体介导内吞及其应用

尿激酶型纤溶酶原激活物 (ｕＰＡ)是参与细胞外基质降解的重要成分 ,在肿瘤细胞的侵袭和转移中起着重要作用。人们对ｕＰＡ的结构、功能以及它与纤溶酶原激活抑制物 1 (ＰＡＩ 1 )、ｕＰＡ受体 (ｕＰＡＲ)的相互作用都进行了深入的研究。单链ｕＰＡ是一种糖蛋白 ,含有 41 1个氨基酸。其结构可分为四部分 ,依次为 :上皮生长因子区、环状结构区、连接区和丝氨酸蛋白酶区。纤溶酶可裂解Ｌｙｓ1 5 8 Ｉｌｅ1 5 9之间的肽键 ,使单链ｕＰＡ转变为双链ｕＰＡ。ｕＰＡ与其细胞表面受体结合后激活纤溶酶原 ,自身激活也增强。结合在细胞膜上的ｕＰＡ…     

脑内的铁,转铁蛋白及转铁蛋白受体

脑铁异常增高可能参与脑神经变性疾病的发生发展。这一发现使得脑铁代谢成为近年广为关注和研究较为广泛的领域。本文综述了这一领域某些方面的目前认识。包括：（１）脑铁分布及功能;（２）铁转铁蛋白及转铁蛋白受体在脑内的合成与分布;（３）脑铁摄取和运输。此外,对铁与某些金属离子,转的蛋白和转铁蛋白受体与脑神经变性疾病的关系,以及转铁蛋白受体内吞在生物大分子跨血脑屏障运输中的作用也作了简要讨论。     

转铁蛋白糖链结构对其受体亲和性的影响

用伴刀豆凝集素,小扁豆凝集素和欧曼陀罗凝集素亲和层析法,分别从正常人血清转铁蛋白和孕妇血清Ｔｆ中获得二天线糖链Ｔｆ和多天线糖链的Ｔｆ,用于研究其对胎盘中纯化得到的转铁蛋白受体和亲和性。经Ｓｃａｔｃｈａｒｄ作图结果发现,表明含多天线糖链的Ｔｆ对受体的亲和性比二天线糖链的Ｔｆ降低１倍,而ＴｆＲ的结合位点数不变。     

转铁蛋白糖链结构对受体亲和性的影响

用伴刀豆凝集素（ＣｏｎＡ）,小扁豆凝集素（ＬＣＡ）,和欧曼陀罗凝集素（ＤＳＡ）亲和层析法,分别从正常人血清转铁蛋白（Ｔｆ）和孕妇血清Ｔｆ中获得二天线糖链的Ｔｆ和多天线糖链的Ｔｆ．用于研究其对从胎盘中纯化得到的转铁蛋白受体（ＴｆＲ）的亲和性。经Ｓｃａｔｃｈａｒｄ作图结果发现,解离常数分别为：４．９７×１０－８ｍｏｌ／Ｌ和９．８０×１０－８ｍｏｌ／Ｌ．最大结合分别是１８０ｆｍｏｌ／Ｌ和１８２ｆｍｏｌ／Ｌ,表明含多天线糖链的Ｔｆ对受体的亲和性比二天线糖链的Ｔｆ降低１倍,而ＴｆＲ的结合位点数不变。     

二种癌细胞株的胰岛素及转铁蛋白受体的鉴定

二种癌细胞株的胰岛素及转铁蛋白受体的鉴定唐月华,张新,夏曙莉,景乃禾,冯佑民（中国科学院上海生物化学研究所分子生物学国家重点实验室;中国科学院上海生物化学研究所,２０００３１）关键词人卵巢畸胎癌细胞株ＰＡ－１,小鼠乳腺癌细胞株ＧＲ２Ｈ６,胰岛素受体,...     

Receptor-Mediated Gene Delivery with Non-Viral DNA Carriers

Abstract

To achieve effective nucleic acid-based therapy, natural carriers, i.e. viruses, as well as synthetic carriers have been developed. The majority of the non-viral systems are based on DNA compaction into small particles by cationic compounds, which are most often polymers and lipids. Optimal in vitro gene delivery with the cationic carriers requires an excess of positive charges with respect to DNA phosphates. However, the overall positive charge of these particles limits their application in vivo because: i) the half-life of positively charged DNA complexes, injected intravenously, is very short, and ii) it does not allow site-specific delivery of the gene of interest. To overcome this problem, the most attractive strategy consists in replacing the non-specific electrostatic interactions between cells and the transfection complexes with a cell-specific interaction that triggers a receptor-mediated endocytosis of the targeted DNA complexes. Such an active targeting requires the identification of receptors present at the surface of the target cells and the use of ligands which binds with a high specificity and affinity to such recognition sites. In this review, we will focus on three examples of receptors that have been used for the targeting of DNA complexes: the Gal/GalNAc receptor followed by the integrin- and folate receptors. Some important principles underlying targeted transfection will also be evoked such as the importance of the conjugation chemistry, the nature of the ligand-receptor interactions, the occurrence of limited windows of the complex charge where targeting is observed.     

青蒿琥酯抑制白血病耐药细胞株K562/ADM转铁蛋白受体表达

目的:观察青蒿琥酯对于白血病多药耐药细胞细胞株K562/ADM转铁蛋白受体表达的影响。方法:将K562/ADM(耐阿霉素)细胞分别经浓度为12.5、25、50μg/m L的青蒿琥酯处理48 h,同时25μg/m L实验组在12 h、24 h、36 h分别收集足量细胞。采用流式细胞术检测青蒿琥酯对细胞转铁蛋白受体(Tf R)密度的调控作用,Western blot检测青蒿琥酯对细胞Tf R蛋白表达的调控作用。CCK-8法分析青蒿琥酯对K562/ADM细胞生长增殖的影响。结果:K562/ADM细胞Tf R密度和Tf R蛋白表达水平分别经12.5、25、50μg/m L青蒿琥酯处理后均下降,呈浓度依赖性。25μg/m L青蒿琥酯处理K562/ADM细胞不同时间段后转铁蛋白受体蛋白表达水平随着Art作用时间延长而逐渐降低,表明呈时间依赖性。K562/ADM细胞经青蒿琥酯处理后其耐药性减弱:与对照组相比,12.5、25、50μg/m L实验组细胞耐药逆转倍数分别为1.38、2.12和2.95倍,从而抑制K562/ADM细胞增殖。IC50值为19.7μmol/L。结论:青蒿琥酯能降低细胞Tf R密度和下调Tf R蛋白的表达,逆转K562/ADM细胞的耐药性,从而起到抗肿瘤作用。     

Quantification of Different Transferrin Receptor Pools in Primary Cultures of Porcine Blood-Brain Barrier Endothelial Cells

Abstract: Distribution of iron in the brain varies with region, cell type, and age. Furthermore, some neurological diseases are accompanied by an abnormal accumulation of iron in specific areas of the CNS. These findings implicate a mobile intracerebral iron pool; however, transport of iron across the blood-brain barrier and its regulation are largely unknown. In an extensive series of experiments in primary cultures of porcine blood-brain barrier endothelial cells, we separately quantified surface-bound and total cellular transferrin receptor pools. Although 90% of all transferrin receptors were located inside the cell, only 10% of these intracellular receptors actively took part in the endocytic cycle. This large "inactive" intracellular transferrin receptor pool could either function as a storage site for spare receptors or be activated by the cell to increase its capacity for iron transport. Data were corrected for nonspecific binding by a separate biochemical assessment using a 100-fold excess of unlabeled ligand. Data were also analyzed in a nonlinear curve-fit program. This resulted in a less elaborate and less biased estimate of nonspecific binding.     

Uptake and Distribution of Iron and Transferrin in the Adult Rat Brain

Brain uptake of iron-59 and iodine-125-labelled transferrin from blood in the adult rat has been investigated using graphical analysis to determine the blood-brain barrier permeability to these tracers in experiments that lasted between 5 min and 8 days. The blood-brain barrier permeability (K(in)) to 59Fe was 89 x 10(-5) ml/min/g compared to the value of 7 x 10(-5) ml/min/g for 125I-transferrin, which is similar to that of albumin, a plasma marker. The autoradiographic distribution of these tracers in brain was also studied to determine any regional variation in brain uptake after the tracers had been administered either systemically or applied in vitro. No regional uptake was seen for 125I-transferrin even after 24 h of circulation. In contrast, 59Fe showed selective regional uptake by the choroid plexus and extra-blood-brain barrier structures 4 h after administration. After 24 h of circulation, 59Fe distribution in brain was similar to the transferrin receptor distribution, as determined in vitro, but was unlike the distribution of nonhaem iron determined histochemically. The data suggest that brain iron uptake does not involve any significant transcytotic pathway of transferrin-bound iron into brain. It is proposed that the uptake of iron into brain involves the entry of iron-loaded transferrin to the cerebral capillaries, deposition of iron within the endothelial cells, followed by recycling of apotransferrin to the circulation. The deposited iron is then delivered to brain-derived transferrin for extracellular transport within the brain, and subsequently taken up via transferrin receptors on neurones and glia for usage or storage.     

Neoglycoproteins as Carriers for Receptor-Mediated Drug Targeting in the Treatment of Experimental Visceral Leishmaniasis

ABSTRACT. Methotrexate (MTX) coupled to mannosyl bovine serum albumin (BSA) was taken up efficiently through the mannosyl receptors present on macrophages. Binding experiments indicate that conjugation does not decrease the affinity of the neoglycoprotein for its cell surface receptor. The drug conjugate eliminated intracellular amastigotes of Leishmania donovani in mouse peritoneal macrophages about 100 times more efficiently than free drug on the basis of 50% inhibitory dose. Inhibitory effect of the conjugate was directly proportional to the density of sugar on the neoglycoprotein carrier. Colchicine and monensin, inhibitors of receptor-mediated endocytosis, can prevent the leishmanicidal effect of the conjugate. Antileishmanial effect of the conjugate can be competitively inhibited by mannose-BSA and mannan. In a murine model of experimental visceral leishmaniasis the drug conjugate reduced the spleen parasite burden by more than 85% in a 30-day model whereas the same concentration of free drug caused little effect. These results indicate that MTX-neoglycoprotein conjugate binds specifically to macrophages, and is internalized and degraded in lysosomes releasing the active drug to act on Leishmania parasites. These results also represent the potential for a general approach to intracellular targeting of clinical agents for macrophage-associated disorders.     

Receptor-Mediated Endocytosis of a Manganese Complex of Transferrin into Neuroblastoma (SHSY5Y) Cells in Culture

Abstract: Exposure to manganese compounds often occurs as the result of industrial production or mining. Although manganese appears in traces in animal and human tissue and is essential to certain biological processes, it is also toxic. In humans and animals, toxicity is mainly associated with the nervous system. The mechanism underlying behavioral and biochemical alterations observed after manganese intoxication is not fully understood. We have shown that the manganese present in serum after exposure to manganese oxide is bound to transferrin as trivalent manganic ion. In this study of manganese uptake and storage we used a clone of human neuroblastoma cells (SHSY5Y). These cells differentiate and express catechol-aminergic properties. Saturation binding analysis of the transferrin-manganese complex to the cells revealed a single class of binding sites, with an apparent K _D of 13 ± 1 n M and a density of 11, 000 ± 2, 000 binding sites per cell. The complex was internalized in a temperature-dependent way and reached saturation after 2 h when ∼2% of the added manganese had been internalized. About 80% of the internalized manganese was found in ferritin after 24 h of exposure. The results demonstrate that the transferrin receptor on SHSY5Y cells can bind and internalize a manganese-transferrin complex as efficiently as an iron-transferrin complex, although a saturation of the manganese uptake was achieved.     

Rate of 59Fe Uptake into Brain and Cerebrospinal Fluid and the Influence Thereon of Antibodies Against the Transferrin Receptor

Abstract: Uptake of ⁵⁹Fe from blood into brains of anaesthetized rats and mice has been studied by intravenous infusion of [⁵⁹Fe]ferrous ascorbate or of ⁵⁹Fe-transferrin, the results not being significantly different. Uptakes in the rat were linear with time, but increased at longer times in the mouse. Transfer constants, K _in (in ml/g/h × 10³), for cerebral hemispheres were 5.2 in the adult rat and 5.6 in the mouse. These K _in values corresponded to ⁵⁹Fe influxes of 145 and 322 pmol/g/h, respectively. ⁵⁹Fe uptake into the mouse brain occurred in the following order: cerebellum > brainstem > frontal cerebral cortex > parietal cortex > occipital cortex > hippocampus > caudate nucleus. In genetically hypotransferrinaemic mice, ⁵⁹Fe uptake into brain was 80–95 times greater than in To strain mice. Pretreatment of young rats and mice with monoclonal antibodies to transferrin receptors, i.e., the anti-rat immunoglobulin G OX 26 and the anti-mouse immunoglobulin M RI7 208, inhibited ⁵⁹Fe uptake into spleen by 94% and 98%, respectively, indicating saturation of receptors. The antibodies reduced ⁵⁹Fe uptake into rat brain by 35–60% and that into mouse brain by 65–85%. Although a major portion of iron transport across the blood-brain barrier is normally transferrin-mediated, non-transferrin-bound iron readily crosses it at low serum transferrin levels.     

Transferrin receptor: Its biological significance

Conclusions The TR is a vital surface component which has been demonstrated to be involved in processes critical for cell metabolism and growth. This review has attempted to briefly touch on the more well understood aspects of study of the TR. These aspects include the biochemical characterization of the TR and the functional studies concerning the central role of the TR in binding transferrin for the purpose of internalization and accumulation of intracellular iron. Other less well-understood and controversial aspects surrounding our present knowledge of the TR have been highlighted and discussed. These include: the nature of the biochemical signal involved in triggering receptor endocytosis; the role for the transferrin-TR interaction or the TR alone in regulation of cellular growth processes; and the possible clinical role(s) for the TR in anti-tumor therapy.